NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:
Gilead Sciences Inc., up 12 cents to $60.79.
Regulators approved the company's antiviral medication remdesivir, the first drug to treat COVID-19.
Mattel Inc., up $1.23 to $14.16.
The maker of Barbie and other toys reported earnings for the summer quarter that blew past analysts' forecasts.
Boston Beer Co., up $173.02 to $1,091.10.
The maker of Sam Adams beer reported quarterly earnings that easily beat analysts' estimates.
Capital One Financial Corp., up $1.24 to $77.99.
The bank and credit card issuer reported earnings and revenue that came in ahead of Wall Street's estimates.
Intel Corp., down $5.70 to $48.20.
The chip maker reported weakness in its data center group in the latest quarter.
American Express, down $3.81 to $100.98.
The credit card issuer reported earnings that fell short of what Wall Street was looking for.
Wells Fargo & Co., up 3 cents to $23.28.
The San Francisco-based bank is reportedly considering a sale of its asset management business.
Uber Technologies Inc., up 5 cents to $36.75.
An appeals court in California upheld an order requiring Uber and Lyft to treat their drivers in that state as employees.
Before you consider Gilead Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.
While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
